Willingness and Hesitancy to Vaccinate Against COVID-19 in People with Multiple Sclerosis
Introduction. During the pandemic, vaccination against COVID-19 has become one of the most important ways to prevent severe infection. However, a lack of trust in vaccines among the population, including people with multiple sclerosis (MS) has been identified. In Lithuania, the specific reasons for...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Vilnius University Press
2023-11-01
|
| Series: | Neurologijos seminarai |
| Subjects: | |
| Online Access: | https://www.journals.vu.lt/neurologijos_seminarai/article/view/33565 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832593114843316224 |
|---|---|
| author | D. Bučaitė J. Valinčiūtė D. Mickevičienė |
| author_facet | D. Bučaitė J. Valinčiūtė D. Mickevičienė |
| author_sort | D. Bučaitė |
| collection | DOAJ |
| description |
Introduction. During the pandemic, vaccination against COVID-19 has become one of the most important ways to prevent severe infection. However, a lack of trust in vaccines among the population, including people with multiple sclerosis (MS) has been identified. In Lithuania, the specific reasons for vaccine hesitancy among people with MS have not been described. We conducted a survey to determine the attitude of people with MS towards vaccination against COVID-19 infection.
Methods. An original anonymous questionnaire was created. The survey included the following aspects: patient demographics, MS exacerbation, COVID-19 vaccination status, and attitudes towards the vaccination process. The survey was conducted between November 2021 and February 2022. Data were analyzed using IBM SPSS Statistics 27.0 with Chi-square and Mann-Whitney U tests and p-value (statistically significant at <0.05) for each hypothesis.
Results. Of the 80 MS patients, 82.5% (n=66) were vaccinated and only 17.5% (n=14) were not vaccinated. The most popular positive opinions about vaccination were: “COVID-19 vaccines have more benefits than harm” (71.6%) and “the desire to prevent severe symptoms/hospitalization caused by COVID-19 infection” (79.1%), while mostly agreed negative opinion was “fear of side effects of the vaccine” (84.6%). Intended uptake of COVID-19 vaccines was strongly associated with younger age (p=0.021), higher education level (p=0.008), and employment status (p=0.028). There was no further link between other demographic factors such as gender, residency, and even exacerbation of MS between January 1, 2020 and February 1, 2022 (p>0.05).
Conclusion. Although there was some hesitancy about the COVID-19 vaccination, people with MS were more likely to take the COVID-19 vaccine due to their positive attitude towards the process.
|
| format | Article |
| id | doaj-art-8d2f77f474c144c590136cc1a4881f62 |
| institution | Kabale University |
| issn | 1392-3064 2424-5917 |
| language | English |
| publishDate | 2023-11-01 |
| publisher | Vilnius University Press |
| record_format | Article |
| series | Neurologijos seminarai |
| spelling | doaj-art-8d2f77f474c144c590136cc1a4881f622025-01-20T18:22:03ZengVilnius University PressNeurologijos seminarai1392-30642424-59172023-11-0127No. 1 (95)10.29014/NS.2023.27.5Willingness and Hesitancy to Vaccinate Against COVID-19 in People with Multiple SclerosisD. Bučaitė0J. Valinčiūtė1D. Mickevičienė2Vilnius University, LithuaniaVilnius University, LithuaniaLithuanian University of Health Sciences Introduction. During the pandemic, vaccination against COVID-19 has become one of the most important ways to prevent severe infection. However, a lack of trust in vaccines among the population, including people with multiple sclerosis (MS) has been identified. In Lithuania, the specific reasons for vaccine hesitancy among people with MS have not been described. We conducted a survey to determine the attitude of people with MS towards vaccination against COVID-19 infection. Methods. An original anonymous questionnaire was created. The survey included the following aspects: patient demographics, MS exacerbation, COVID-19 vaccination status, and attitudes towards the vaccination process. The survey was conducted between November 2021 and February 2022. Data were analyzed using IBM SPSS Statistics 27.0 with Chi-square and Mann-Whitney U tests and p-value (statistically significant at <0.05) for each hypothesis. Results. Of the 80 MS patients, 82.5% (n=66) were vaccinated and only 17.5% (n=14) were not vaccinated. The most popular positive opinions about vaccination were: “COVID-19 vaccines have more benefits than harm” (71.6%) and “the desire to prevent severe symptoms/hospitalization caused by COVID-19 infection” (79.1%), while mostly agreed negative opinion was “fear of side effects of the vaccine” (84.6%). Intended uptake of COVID-19 vaccines was strongly associated with younger age (p=0.021), higher education level (p=0.008), and employment status (p=0.028). There was no further link between other demographic factors such as gender, residency, and even exacerbation of MS between January 1, 2020 and February 1, 2022 (p>0.05). Conclusion. Although there was some hesitancy about the COVID-19 vaccination, people with MS were more likely to take the COVID-19 vaccine due to their positive attitude towards the process. https://www.journals.vu.lt/neurologijos_seminarai/article/view/33565multiple sclerosisCOVID-19vaccination |
| spellingShingle | D. Bučaitė J. Valinčiūtė D. Mickevičienė Willingness and Hesitancy to Vaccinate Against COVID-19 in People with Multiple Sclerosis Neurologijos seminarai multiple sclerosis COVID-19 vaccination |
| title | Willingness and Hesitancy to Vaccinate Against COVID-19 in People with Multiple Sclerosis |
| title_full | Willingness and Hesitancy to Vaccinate Against COVID-19 in People with Multiple Sclerosis |
| title_fullStr | Willingness and Hesitancy to Vaccinate Against COVID-19 in People with Multiple Sclerosis |
| title_full_unstemmed | Willingness and Hesitancy to Vaccinate Against COVID-19 in People with Multiple Sclerosis |
| title_short | Willingness and Hesitancy to Vaccinate Against COVID-19 in People with Multiple Sclerosis |
| title_sort | willingness and hesitancy to vaccinate against covid 19 in people with multiple sclerosis |
| topic | multiple sclerosis COVID-19 vaccination |
| url | https://www.journals.vu.lt/neurologijos_seminarai/article/view/33565 |
| work_keys_str_mv | AT dbucaite willingnessandhesitancytovaccinateagainstcovid19inpeoplewithmultiplesclerosis AT jvalinciute willingnessandhesitancytovaccinateagainstcovid19inpeoplewithmultiplesclerosis AT dmickeviciene willingnessandhesitancytovaccinateagainstcovid19inpeoplewithmultiplesclerosis |